Replies to post #283553 on Anavex Life Sciences Corp (AVXL)

[falconer66a]

Prophylaxis, again.

"...Further data also demonstrates that ANAVEX®2-73 provides protection for OL, OPC’s, as well as central nervous system neurons in addition to helping repair by increasing OPC proliferation and maturation in tissue culture.“

Thank you for posting this statement from a scientist working on brain cells. Brain science, if you will. The guy isn't making things up.

From the start, I've contended that the greatest, best use of the Anavex sigma-1 receptor agonists will prove to be that they not only restore or facilitate normal neuron functions (treat diseases), but will be able to actually prevent their onset. That's "prophylaxis," the prevention of a disease before it appears or advances.

I anticipate that in five years or so, after blarcamesine and Anavex 3-71 have demonstrated profound treatment efficacies against a number of central nervous system (CNS) diseases, they will be prescribed, prophylactically, to "vulnerable people," which is just about everyone over the age of 45 or 50, to prevent the diseases.

What would be the size of that market, at even a daily dosing cost of $3 a day?